203 related articles for article (PubMed ID: 2138609)
1. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
Derechin VM; Blinder MA; Tollefsen DM
J Biol Chem; 1990 Apr; 265(10):5623-8. PubMed ID: 2138609
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
Van Deerlin VM; Tollefsen DM
J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
[TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
Blinder MA; Tollefsen DM
J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
[TBL] [Abstract][Full Text] [Related]
4. Characterization of recombinant heparin cofactor II expressed in insect cells.
Ciaccia AV; Cunningham EL; Church FC
Protein Expr Purif; 1995 Dec; 6(6):806-12. PubMed ID: 8746633
[TBL] [Abstract][Full Text] [Related]
5. Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibition.
Ciaccia AV; Monroe DM; Church FC
J Biol Chem; 1997 May; 272(22):14074-9. PubMed ID: 9162031
[TBL] [Abstract][Full Text] [Related]
6. Heparin facilitates dissociation of complexes between thrombin and a reactive site mutant (L444R) of heparin cofactor II.
Han JH; Van Deerlin VM; Tollefsen DM
J Biol Chem; 1997 Mar; 272(13):8243-9. PubMed ID: 9079643
[TBL] [Abstract][Full Text] [Related]
7. Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II.
Ciaccia AV; Willemze AJ; Church FC
J Biol Chem; 1997 Jan; 272(2):888-93. PubMed ID: 8995378
[TBL] [Abstract][Full Text] [Related]
8. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition.
Mitchell JW; Church FC
J Biol Chem; 2002 May; 277(22):19823-30. PubMed ID: 11856753
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of heparin cofactor II anticoagulant activity.
Bauman SJ; Church FC
J Biol Chem; 1999 Dec; 274(49):34556-65. PubMed ID: 10574918
[TBL] [Abstract][Full Text] [Related]
10. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
[TBL] [Abstract][Full Text] [Related]
11. Activation of heparin cofactor II by calcium spirulan.
Hayakawa Y; Hayashi T; Lee JB; Ozawa T; Sakuragawa N
J Biol Chem; 2000 Apr; 275(15):11379-82. PubMed ID: 10753952
[TBL] [Abstract][Full Text] [Related]
12. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
13. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
[TBL] [Abstract][Full Text] [Related]
14. Contribution of basic residues of the A helix of heparin cofactor II to heparin- or dermatan sulfate-mediated thrombin inhibition.
Hayakawa Y; Hirashima Y; Kurimoto M; Hayashi N; Hamada H; Kuwayama N; Endo S
FEBS Lett; 2002 Jul; 522(1-3):147-50. PubMed ID: 12095635
[TBL] [Abstract][Full Text] [Related]
15. Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
Blinder MA; Andersson TR; Abildgaard U; Tollefsen DM
J Biol Chem; 1989 Mar; 264(9):5128-33. PubMed ID: 2647747
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thrombin by sulfated polysaccharides isolated from green algae.
Hayakawa Y; Hayashi T; Lee J; Srisomporn P; Maeda M; Ozawa T; Sakuragawa N
Biochim Biophys Acta; 2000 Nov; 1543(1):86-94. PubMed ID: 11087944
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of chymotrypsin by heparin cofactor II.
Church FC; Noyes CM; Griffith MJ
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6431-4. PubMed ID: 3863104
[TBL] [Abstract][Full Text] [Related]
18. The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation.
Parker KA; Tollefsen DM
J Biol Chem; 1985 Mar; 260(6):3501-5. PubMed ID: 3838315
[TBL] [Abstract][Full Text] [Related]
19. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
Sheehan JP; Tollefsen DM; Sadler JE
J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
